BUILDING CONFIDENCE IN
THE FUTURE OF CANCER TREATMENT

There is an urgency for change at ESTRO 2017.

As the definition of value in cancer treatment evolves, YOU are the architects tasked with building a radiotherapy practice that can achieve the outcomes that matter most.

Visit the Accuray booth at ESTRO 2017 and INSPIRE THE ARCHITECT IN YOU.

SEE ACCURAY INNOVATIONS

Radixact™ Treatment Delivery System

The next generation TomoTherapy platform, the world’s first fully integrated, data-driven radiation therapy treatment planning and delivery system.

CyberKnife® M6™ System

The most advanced CyberKnife ever, delivering unrivaled precision to create entirely new treatment possibilities.

Accuray™ Precision Treatment Planning System

Centralized planning and control for all Accuray treatment delivery systems. The integrated planning platform includes the Accuray PreciseART™ Adaptive Radiation Therapy Option and Accuray PreciseRTX™ Retreatment Option—two tools that leverage highly automated workflows to enable you to deliver more personalized and precise treatment plans to a much wider range of patients.

RayStation Treatment Planning System

The latest release of RaySearch’s innovative TPS provides a single point of control for all your treatment planning needs including support for the Radixact and TomoTherapy Systems*. With access to all RayStation’s advanced functionality, including multi-criteria optimization and adaptive planning, the user can efficiently design the optimal treatment plan and ensure the treatment stays on track. Learn more at raysearchlabs.com/raystation6

*Not currently available for commercial distribution, not 510k cleared or CE marked

ACCURAY SYMPOSIUM

Advanced | Personalized | Integrated

Saturday, 6 May: 13:15 to 14:15
Stolz Rooms 1 & 2.

Moderator: Mrs. Birgit Fleurent, VP Marketing, Patient Access and Customer Loyalty, Accuray

Welcome and Latest News

Robert Hill, Senior Vice President R&D and Chief Product Officer, Accuray

Radiotherapy: A Central Role in Driving Treatment for All

Dr. Cary Adams, CEO, Union for International Cancer Control (UICC) and Chair, NCD Alliance, Geneva, Switzerland

Prostate Hypofractionation: How High and Fast Can We Go?

Prof. Vincent Khoo, The Royal Marsden NHS Foundation Trust, London, United Kingdom

TomoTherapy® Treats all Breasts

Prof. Roberto Orecchia, Chair of Radiation Therapy, University of Milan and Scientific Director at the European Institute of Oncology (IEO), Milan, Italy

AERO™ ACADEMY

Concise, interactive talks on the real-world implementation of Accuray technologies

All AERO talks hosted in-booth—no reservation required.

SATURDAY, MAY 6

10:05

10:25

Tailored Total Body Radiotherapy with Advanced Helical IMRT

Prof. Stefano Vagge, IRCCS Azienda Ospedaliera Universitaria San Martino - IST - Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy

16:05

16:25

Breast Clinical Experience with TomoDirect™ Tangential Mode

Dr. Maria Cristina Leonardi, Istituto Europeo di Oncologia (IEO), Milan, Italy

SUNDAY, MAY 7

10:05

10:25

Multiple Brain Metastases with the CyberKnife® System

Prof. Frédéric Dhermain, Gustave Roussy Cancer Campus, Paris, France

13:05

13:25

CyberKnife SBRT for Prostate Cancer

Dr. Robert M. Meier, Swedish Medical Center, Seattle, USA

13:35

13:55

Commissioning and Ramp-Up of a Radixact™ System at IUCT Oncopole

Dr. Eliane Graulières, IUCT Oncopole, Toulouse, France

14:05

14:25

The Role of Synchrony® in the Management of Primary and Secondary Lung Tumors

Mr. Lukáš Knybel, University Hospital of Ostrava, Ostrava, Czech Republic

16:05

16:25

TomoTherapy® Planning in RayStation

Mr. Björn Hårdemark, RaySearch Laboratories AB, Stockholm, Sweden

MONDAY, MAY 8

10:05

10:25

Rationale for Adding a Non-Invasive Robotic Radiosurgery System in a Multi-Platform Radiotherapy Department

Prof. Nadia Di Muzio, The San Raffaele Scientific Institute, Milan, Italy

13:30

13:50

Tips and Tricks to Safely Treat Central Lung Tumors

Dr. Aman Sharma, Regional Cancer Centre, Indira Gandhi Medical College, Shimla, India

Dr. Joost Nuyttens, Erasmus MC Cancer Institute, Rotterdam, The Netherlands

14:00

14:20

Dosimetric Comparison of Xsight® Spine Prone Versus Supine

Mr. Nadir Küçük, University of Medipol Mega Hospital, Istanbul, Turkey

16:05

16:25

Reporting, Margins and Clinical Indicators in Adaptive Radiotherapy

Mr. Edmond Sterpin, University Catholique de Louvain (UCL), Brussels, Belgium

DOWNLOAD SCHEDULES

Download the event schedules in PDF format.

Accuray, the stylized logo, CyberKnife, TomoTherapy, Synchrony, Xsight, Xchange, TomoHD, Hi•Art, and RoboCouch are among the trademarks and / or registered trademarks of Accuray Incorporated in the United States and other countries.

Important Safety Statement: Most side effects of radiotherapy, including radiotherapy delivered with Accuray systems, are mild and temporary, often involving fatigue, nausea, and skin irritation. Side effects can be severe, however, leading to pain, alterations in normal body functions (for example, urinary or salivary function), deterioration of quality of life, permanent injury and even death.

Side effects can occur during or shortly after radiation treatment or in the months and years following radiation. The nature and severity of side effects depend on many factors, including the size and location of the treated tumor, the treatment technique (for example, the radiation dose), the patient's general medical condition, to name a few. For more details about the side effects of your radiation therapy, and if treatment with an Accuray product is right for you, ask your doctor.